Are you finished with surgery or chemotherapy for early stage colon cancer?
Would you like a chance to see if a new experimental treatment can reduce your risk of
- A new polyp in your colon?
- Colon cancer spreading beyond your colon?
- A new colon cancer?
Researchers at the National Surgical Adjuvant Breast and Bowel Project (NSABP) would like to talk to you about a clinical trial exploring whether a statin drug can reduce the risk of new polyps, colon cancer recurrence, or a new primary colon cancer.
In the P-5 clinical trial stage I and II colon cancer patients will be randomly assigned to take either rosuvastatin (Crestor®) or an inert placebo for five years. Read the rest of this entry »






